Metraipolis › archive › dc_9ea2e65121cf

Clinical course, treatment and outcome of severe pneumocystis pneumonia in patients with autoimmune or inflammatory diseases: a prospective study — Europe PMC PMID:42282276

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42282276
DOI
10.3389/fcimb.2026.1715992
License (as archived)
solo-consultazione
Archived
2026-11-01T06:29:04.970Z
SHA-256 of the archived text
e3cbade2be75828608d316e27563665fafe3afdf78a55bb16a445a3717bb4528
Stable URL of this page
https://metraipolis.com/documento/dc_9ea2e65121cf

How to cite

Clinical course, treatment and outcome of severe pneumocystis pneumonia in patients with autoimmune or inflammatory diseases: a prospective study — Europe PMC PMID:42282276 — Europe PMC (en), https://europepmc.org/article/MED/42282276 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9ea2e65121cf (Metraipolis archive dc_9ea2e65121cf, sha256 e3cbade2be75828608d316e27563665fafe3afdf78a55bb16a445a3717bb4528)
BibTeX
@misc{dc9ea2e65121cf,
  title = {Clinical course, treatment and outcome of severe pneumocystis pneumonia in patients with autoimmune or inflammatory diseases: a prospective study — Europe PMC PMID:42282276},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42282276},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9ea2e65121cf; sha256 e3cbade2be75828608d316e27563665fafe3afdf78a55bb16a445a3717bb4528},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42282276. Agents can read the archived copy with the MCP tool read_document.